NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Dstock, I would like to add that once NWBO buys Oncovir, the pending expiration of Oncovir's Poly ICLC patent would not constitute a problem because as ATL has been pointing out, Poly ICLC is an essential and integral component of DCVax-L . Hence Poly ICLC will be something like an unofficial patented component of the patented DCVax-L vaccine.

Oncovir's fate as a company will therefore become irrelevant while their main product persists. As a ridiculous analogy I will mention the fate of the Neanderthal species that are extinct but some of their genes are still an integral component of the genetic makeup of most human beings on this planet.